Woodline Partners LP Atai Life Sciences N.V. Transaction History
Woodline Partners LP
- $13.5 Billion
- Q4 2024
A detailed history of Woodline Partners LP transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Woodline Partners LP holds 562,372 shares of ATAI stock, worth $1.29 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
562,372
Previous 535,047
5.11%
Holding current value
$1.29 Million
Previous $620,000
20.48%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding ATAI
# of Institutions
101Shares Held
14.8MCall Options Held
168KPut Options Held
77.9K-
Morgan Stanley New York, NY3.33MShares$7.66 Million0.0% of portfolio
-
Ubs Group Ag1.94MShares$4.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$3.01 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny982KShares$2.26 Million0.0% of portfolio
-
Davidson Kempner Capital Management LP New York, NY949KShares$2.18 Million0.03% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $382M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...